Clinical trial

Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer

NCT03679819

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention HR-TRUS Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-09-05

PhaseN/A

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

HR-TRUSDEVICE

Sponsors & collaborators

Institut Paoli-Calmetteslead sponsor

Exact Imagingcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03679819 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.